Skip to main content

Midface Volume Deficit

0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Galderma
GaldermaTX - Dallas
3 programs
Restylane Perlane LidocaineN/A1 trial
Restylane VolymeN/A1 trial
SculptraN/A1 trial
Active Trials
NCT03097783Completed169Est. Sep 2018
NCT03289052Completed168Est. Jul 2019
NCT04132518Completed205Est. Jul 2022
Croma-Pharma
Croma-PharmaAustria - Leobendorf
1 program
Dermal filler for midface deficitN/A1 trial
Active Trials
NCT03532126Completed91Est. Jun 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GaldermaSculptra
Croma-PharmaDermal filler for midface deficit
GaldermaRestylane Volyme
GaldermaRestylane Perlane Lidocaine

Clinical Trials (4)

Total enrollment: 633 patients across 4 trials

NCT04132518GaldermaSculptra

Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency

Start: Nov 2019Est. completion: Jul 2022205 patients
N/ACompleted
NCT03532126Croma-PharmaDermal filler for midface deficit

A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit

Start: Mar 2018Est. completion: Jun 202091 patients
N/ACompleted
NCT03289052GaldermaRestylane Volyme

Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency

Start: Dec 2017Est. completion: Jul 2019168 patients
N/ACompleted
NCT03097783GaldermaRestylane Perlane Lidocaine

Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency

Start: Apr 2017Est. completion: Sep 2018169 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.